Understanding preferences for long-acting HIV treatment among Black women in the South
Official title: PS23-003 - A Community-based Assessment of Preferences for Long-Acting Antiretroviral Therapy Options Among Cis-gender Black Women across Six Ending the HIV Epidemic Jurisdictions in the South
Funded at Emory University · NIH-10917005 · Data updated 2026-11-12
This study is looking at what Black women living with HIV in the Southern U.S. like and struggle with when it comes to long-acting treatments, so we can create helpful resources that make it easier for them to get and stick with their care.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $332,759 |
| NIH project number | 5U01PS005260-02 |
| Project ID | NIH-10917005 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cis-gender Black women living with HIV, particularly those residing in the Southern United States.
✕Less likely to help
Patients who are not cis-gender Black women or those living outside the Southern United States may not benefit from this research.
What this research studies
This research investigates the preferences and challenges faced by cis-gender Black women living with HIV in the Southern United States regarding long-acting antiretroviral therapy (ART). By engaging with the community, the study aims to identify barriers to accessing and adhering to these treatment options. The research will utilize a mixed-methods approach, combining qualitative and quantitative data to co-create educational tools and referral systems tailored to the needs of these women. The goal is to enhance care linkage and improve treatment adherence among this population.
Why it matters
Potential benefit: If successful, this research could lead to improved access and adherence to long-acting HIV treatments for cis-gender Black women, ultimately enhancing their health outcomes.
How similar studies have gone: Previous research has shown promise in understanding treatment preferences among women, but this specific focus on cis-gender Black women and long-acting ART in the Southern US is relatively novel.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Collins, Lauren Frances — Emory University
- Study coordinator: Collins, Lauren Frances
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.